Clinical Science
Full Access
HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
Ulf Wagner MD, Sylke Kaltenhäuser MD, Heidemarie Sauer PhD, Sybille Arnold MD, Wolfram Seidel MD, Holm Häntzschel MD, Joachim R. Kalden MD,
Ralf Wassmuth MD,
Joachim R. Kalden MD
University of Erlangen-Nuremberg, Erlangen, Germany
Search for more papers by this authorCorresponding Author
Ralf Wassmuth MD
University of Erlangen-Nuremberg, Erlangen, Germany
Institute for Clinical Immunology, Department of Medicine III, University of Erlangen-Nuremberg, Krankenhaustrasse 12, 91054 Erlangen, GermanySearch for more papers by this authorUlf Wagner MD, Sylke Kaltenhäuser MD, Heidemarie Sauer PhD, Sybille Arnold MD, Wolfram Seidel MD, Holm Häntzschel MD, Joachim R. Kalden MD,
Ralf Wassmuth MD,
Joachim R. Kalden MD
University of Erlangen-Nuremberg, Erlangen, Germany
Search for more papers by this authorCorresponding Author
Ralf Wassmuth MD
University of Erlangen-Nuremberg, Erlangen, Germany
Institute for Clinical Immunology, Department of Medicine III, University of Erlangen-Nuremberg, Krankenhaustrasse 12, 91054 Erlangen, GermanySearch for more papers by this authorAbstract
Objective. To evaluate HLA markers as early prognostic factors for disease severity in rheumatoid arthritis (RA).
Methods. HLA genotyping was carried out in a retrospective analysis of 66 RA patients and in a prospective study of 55 RA patients and 87 healthy controls using polymerase chain reaction-based methods for HLA-DRB1 specificities, DR4 alleles, and their linked DQB1 alleles, as well as HLA-B27. The clinical course of RA was assessed by clinical and radiologic scores. The impact of HLA markers was evaluated by epidemiologic means in addition to modeling using multiple logistic regression analysis.
Results. Shared epitope-positive (HVR3+) DR4 alleles and the HVR3 amino acid cassette QKRAA were associated with RA in both longstanding (relative risk [RR] 3.34 and 3.19) and recent-onset (RR 2.1 and 2.37) RA. In longstanding RA, radiologic evidence of severe joint destruction (Larsen score > 1.62) was seen more often in HVR3 shared epitope-positive patients than in epitope-negative patients (odds ratio [OR] = 25.67, X2 = 13.59, P = 0.0003). Moreover, rank sum analysis of Larsen indices indicated significantly higher ranking for the presence of the RA-associated HVR3 cassettes (QKRAA, QRRAA) when expressed on a DR4 allele (P < 0.0001). In the prospective study, DR4-positive patients had a significantly increased risk (OR = 13.75, P = 0.00083) of developing bony erosions. In addition, HVR3 epitope-positive DR4-positive individuals had significantly higher Larsen indices than did epitope-negative patients (P = 0.0083). In particular, the presence of the HVR3 epitope on DR4 resulted in an increased a posteriori likelihood (0.91) of developing early erosive disease compared with an a priori risk of 0.62. Conversely, the likelihood decreased to a minimum of 0.35 when the HVR3 epitope was absent.
Conclusion. While the contribution of HLA typing to establishing the diagnosis of RA is limited, HLA-DR genotyping and DR4 subtype determination provide valuable markers for the prognosis of joint destruction in RA.
References
- 1 Harris EDJ: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322: 1277–1289, 1990
- 2 Deighton CM, Wentzel J, Cavanagh G, Roberts DF, Walker DJ: Contribution of inherited factors to rheumatoid arthritis. Ann Rheum Dis 51: 182–185, 1992
- 3 Stastny P: Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298: 869–871, 1978
- 4 Ohta N, Nishimura YK, Tanimoto K, Horiuchi Y, Abe C, Shiokawa Y, Abe T, Katagiri M, Yoshiki T, Sasazuki T: Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 5: 123–132, 1982
- 5 Kim HY, Kim TG, Park SH, Lee SH, Cho CS, Han H: Predominance of HLA-DRB1 *0405 in Korean patients with rheumatoid arthritis. Ann Rheum Dis 54: 988–990, 1995
- 6 Tan PLJ, Farmiloe S, Roberts M, Geursen A, Skinner MA: HLA-DR4 subtypes in New Zealand Polynesians: predominance of Dw13 in the healthy population and association of Dw15 with rheumatoid arthritis. Arthritis Rheum 36: 15–19, 1993
- 7 Nichol FE, Woodrow JC: HLA DR antigens in Indian patients with rheumatoid arthritis. Lancet 1: 220–221, 1981
- 8 Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30: 1205–1213, 1987
- 9 Cairns JS, Curtsinger JM, Dahl CA, Freeman S, Alter BJ, Bach FH: Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature 317: 166–168, 1985
- 10 Weyand CM, Hicok KC, Conn DL, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117: 801–806, 1992
- 11 Willkens RF, Nepom GT, Marks CR, Nettles JW, Nepom BS: Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians: further evidence for the “shared epitope” hypothesis. Arthritis Rheum 34: 43–47, 1991
- 12 Nelson JL, Boyer G, Templin D, Lanier A, Barrington R, Nisperos B, Smith A, Mickelson E, Hansen JA: HLA antigens in Tlingit Indians with rheumatoid arthritis. Tissue Antigens 40: 57–63, 1992
- 13 Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, Garcia A, Nuñez-Roldan A, Sanchez B:xs Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 36: 811–814, 1993
- 14 Duquesnoy RJ, Marrari M, Hackbarth S, Zeevi A: Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis. Hum Immunol 10: 165–176, 1984
- 15 Drover S, Marshall WH, Kwok WW, Nepom GT, Karr RW: Amino acids in the peptide-binding groove influence an antibody-defined, disease-associated HLA-DR epitope. Scand J Immunol 39: 539–550, 1994
- 16 Weyand CM, Goronzy JJ: Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis: functional role in antigen-specific and allogeneic T cell recognition. J Clin Invest 85: 1051–1057, 1990
- 17 Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F: Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181: 1847–1855, 1995
- 18 Westedt ML, Breedveld FC, Schreuder GM, D'Amaro J, Cats A, de Vries RR: Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis 45: 534–538, 1986
- 19 Calin A, Elswood J, Klouda PT: Destructive arthritis, rheumatoid factor, and HLA-DR4: susceptibility versus severity, a case-control study. Arthritis Rheum 32: 1221–1225, 1989
- 20 Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, Birley A, Emery P: Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 37: 1166–1170, 1994
- 21 Toda Y, Minamikawa Y, Akagi S, Sugano H, Mori Y, Nishimura H, Arita S, Sugino Y, Ogawa R: Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA. Ann Rheum Dis 53: 587–592, 1994
- 22 Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS: HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks: the HLA-DRβ shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 35: 749–755, 1992
- 23 Salvarani C, Macchioni P, Mantovani W, Portioli I: Polymyalgia rheumatica and seronegative rheumatoid arthritis: some considerations based on a northern Italian population. J Rheumatol 20: 756–757, 1993
- 24 Vehe RK, Nepom GT, Wilske KR, Stage D, Begovich AB, Nepom BS: Erosive rheumatoid factor negative and positive rheumatoid arthritis are immunogenetically similar. J Rheumatol 21: 194–196, 1994
- 25 Nelson JL, Dugowson CE, Koepsell TD, Voigt LF, Branchaud AM, Barrington RA, Wener MH, Hansen JA: Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis. Arthritis Rheum 37: 673–680, 1994
- 26 Weyand CM, McCarthy TG, Goronzy JJ: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95: 2120–2126, 1995
- 27 Weyand CM, Xie C, Goronzy JJ: Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 89: 2033–2039, 1992
- 28 Nepom GT: Structural and genetic features of human leukocytic antigen class II elements associated with rheumatoid arthritis. Am J Med 85: 12–13, 1988
- 29 Stephens HA, Sakkas LI, Vaughan RW, Teitsson I, Welsh KI, Panayi GS: HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis. Immunogenetics 30: 119–122, 1989
- 30 McCusker CT, Reid B, Green D, Gladman DD, Buchanan WW, Singal DP: HLA-D region antigens in patients with rheumatoid arthritis. Arthritis Rheum 34: 192–197, 1991
- 31 Clarkson R, Bate AS, Grennan DM, Chattopadhyay C, Sanders P, Davis M, Kelly C: DQw7 and the C4B null allele in rheumatoid arthritis and Felty's syndrome. Ann Rheum Dis 49: 976–979, 1990
- 32 Singal DP, Green D, Reid B, Gladman DD, Buchanan WW: HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis 51: 23–28, 1992
- 33 Sansom DM, Bidwell JL, Maddison PJ, Campion G, Klouda PT, Bradley BA: HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis. Hum Immunol 19: 269–278, 1987
- 34 Hillarby MC, Ollier WE, Davis M, Davidson J, Sanders PA, Grennan DM: Unusual DQA-DR haplotypes in rheumatoid vasculitis. Br J Rheumatol 32: 93–96, 1993
- 35 Van Zeben D, Hazes JMW, Zwinderman AH, Cats A, Schreuder GMT, D'Amaro J, Breedveld FC: Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis: results of a followup study. Arthritis Rheum 34: 822–830, 1991
- 36 Eberhardt K, Grubb R, Johnson U, Pettersson H: HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis—their relation to disease progression. J Rheumatol 20: 1825–1829, 1993
- 37 Möttönen TT: Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47: 648–653, 1988
- 38 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324, 1988
- 39 Deighton CM, Kelly PJ, Walker DJ: Linkage of rheumatoid arthritis with HLA. Ann Rheum Dis 52: 638–642, 1993
- 40 Walker DJ, Griffiths M, Dewar P, Coates E, Dick WC, Thompson M, Griffiths ID: Association of MHC antigens with susceptibility to and severity of rheumatoid arthritis in multicase families. Ann Rheum Dis 44: 519–525, 1985
- 41 Larsen A, Dale K, Eek M: Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn Stockh 18: 481–491, 1977
- 42 Larsen A: The value of individual joints for radiologic assessment of rheumatoid arthritis. Scand J Rheumatol 5: 119–123, 1976
- 43 Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 37: 393–406, 1968
- 44 Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1994. Tissue Antigens 44: 1–18, 1994
- 45
Sambrook J,
Fritsch EF,
Maniatis T:
Molecular Cloning: A Laboratory Manual.
Second edition.
Cold Spring Harbor, NY,
Cold Spring Harbor Laboratory Press,
1989
10.1111/j.1095-8312.1996.tb01434.x Google Scholar
- 46 Bein G, Glaser R, Kirchner H: Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 39: 68–73, 1992
- 47 Nevinny-Stickel C, Hinzpeter M, Andreas A, Albert ED: Nonradioactive oligotyping for HLA-DR1-DRw10 using polymerase chain reaction, digoxigenin-labelled oligonucleotides and chemiluminescence detection. Eur J Immunogenet 18: 323–332, 1991
- 48 Tiercy JM, Goumaz C, Mach B, Jeannet M: Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing. Transplantation 51: 1110–1114, 1991
- 49 Bugawan TL, Erlich HA: Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 33: 163–170, 1991
- 50 Olerup O: HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens 43: 253–256, 1994
- 51 Miettinen O: Estimability and estimation in case-referent studies. Am J Epidemiol 103: 226–235, 1976
- 52 Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 19: 251–253, 1955
- 53 Haldane S: The estimated significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20: 309–311, 1956
- 54 Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, Cheah JS, Thomson G: Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 45: 541–546, 1989
- 55 Mantel N, Haenzsel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748, 1959
- 56 Rosner BA: Fundamentals of Biostatistics. Boston, Duxbury Press, 1982
- 57 Katz MA: A probability graph describing the predictive value of a highly sensitive diagnostic test. N Engl J Med 291: 1115–1116, 1974
- 58 De Vries N, Ronningen KS, Tilanus MG, Rombouts A Bouwens, Segal R, Egeland T, Thorsby E, van de Putte LB, Brautbar C: HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 41: 26–30, 1993
- 59 Salvarani C, Macchioni P, Mantovani W, Rossi F, Veneziani M, Boiardi L, Lodi L, Portioli I: Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy. J Rheumatol 19: 242–246, 1992
- 60
Tiwari JL,
Terasaki PI:
The Data and Statistical Analysis, HLA and Disease Associations.
New York,
Springer-Verlag,
1985
10.1007/978-1-4613-8545-5 Google Scholar
